Search

Searching with a thematic focus on HIV and AIDS, Access to treatment, HIV and AIDS treatment and care, ARVs

Showing 51-57 of 57 results

Pages

• Document

  Scaling up antiretroviral therapy: experience in Uganda: case study (Perspectives and Practice in Antiretroviral treatment)

  World Health Organization, 2003

  This case study is part of a series entitled Perspectives and Practice in Antiretroviral treatment, which aims to analyse how governments, civil society organisations, private corporations and others are successfully providing antiretroviral treatment and care to people with HIV/AIDS, even in the most resource-constrained settings.
• Document

  Access to antiretroviral drugs in Brazil

  The Lancet, 2002

  Since 1996, the Brazilian Ministry of Health has guaranteed free and universal access to antiretroviral treatment for people living with HIV/AIDS. Implementation of this policy has had political, financial, and logistical challenges.
• Document

  Generic competition, price and access to medicines: the case of antiretrovirals in Uganda

  Oxfam, 2002

  This paper outlines the findings of Oxfam research into the accessibility of ARV therapy in Uganda since 2000. During that year two important events improved access to these medicines. First, five drug companies agreed to reduce the price of some ARVs under a UNAIDS scheme.
• Document

  Handbook on access to HIV/AIDS-related to treatment: a collection of information, tools and other resources for NGOs, CBOs and PLWHA groups

  International HIV/AIDS Alliance, 2002

  This handbook, aims to provide practical, experience based advice and examples for people and organisation working to improve access to HIV/AIDS treatment.The book explores care and treatment, providing an introduction to links between treatment and prevention and barriers to access to treatment.
• Document

  The FTAA, access to HIV/AIDS treatment, and human rights

  Human Rights Watch, 2002

  This briefing paper begins by giving an outline of the WTO’s Trade Related Aspects of Intellectual Property Agreement (TRIPS) and of the Doha declaration by WTO members, which states that countries can bypass patents in medical emergencies.The paper argues that countries in the Free Trade Area of the Americas (FTAA) should resist pressure from the Office of the United States Trade Representativ
• Document

  Anti-Retroviral (ARV) Treatment in Developing Countries: Questions of Economics, Equity and Ethics [HIV/AIDS]

  AIDS Economics, World Bank, 1998

  Anti-retroviral (ARV) drugs have the potential to dramatically improve the health and extend the lives of some people with HIV/AIDS. Yet the high cost and demanding clinical requirements of these drugs put them out of reach of the vast majority of people with HIV.
• Document

  Drug companies vs. Brazil: the threat to public health

  Oxfam, 2001

  The access of impoverished Brazilians to essential medicines, including those required for treatment of HIV/AIDS, is under threat.

Pages